Mereo BioPharma Group (MREO) Earnings Date, Estimates & Call Transcripts $2.06 +0.10 (+5.10%) Closing price 04:00 PM EasternExtended Trading$2.10 +0.04 (+1.94%) As of 06:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Mereo BioPharma Group Earnings Summary Mereo BioPharma Group issued Q2 2025 earnings on August 12, 2025, reporting an EPS of -$0.02, which missed analysts' consensus estimates of -$0.01 by $0.01. Quarterly revenue was reported to be $0.50 million, below analysts' expectations of $7.80 million. With a trailing EPS of -$0.07, Mereo BioPharma Group's earnings are expected to decrease next year, from ($0.03) to ($0.04) per share. Upcoming Q3 Earnings DateNov. 11Before Market OpensEstimatedConsensus EPS (Aug. 12) -$0.01 Actual EPS (Aug. 12) -$0.02 Missed By -$0.01 Actual Revenue (Aug. 12) $0.50MQ2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)MREO Upcoming EarningsMereo BioPharma Group's next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules. Powered by Get Mereo BioPharma Group Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mereo BioPharma Group and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataMREO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Mereo BioPharma Group Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$0.07$0.07$0.07Q2 20251-$0.01-$0.01-$0.01Q3 20252-$0.02$0.04$0.01Q4 20252-$0.02$0.05$0.02 FY 2025 6 $0.02 $0.15 $0.09 Q1 20261-$0.01-$0.01-$0.01Q2 20261$0.04$0.04$0.04Q3 20261-$0.01-$0.01-$0.01Q4 20261$0.04$0.04$0.04 Mereo BioPharma Group Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/11/2025(Estimated)--------8/12/2025Q2 2025-$0.01-$0.02 -$0.01-$0.02$7.80M$0.50M5/13/2025Q1 2025-$0.01-$0.02 -$0.01-$0.02$72.50M-3/26/2025Q4 2024$0.02-$0.01 -$0.03-$0.01$72.50M-5/15/2024Q1 2024--$0.01--$0.01-- Mereo BioPharma Group Earnings - Frequently Asked Questions When is Mereo BioPharma Group's earnings date? Mereo BioPharma Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based off last year's report dates. Learn more on MREO's earnings history. Did Mereo BioPharma Group beat their earnings estimates last quarter? In the previous quarter, Mereo BioPharma Group (NASDAQ:MREO) missed the analysts' consensus estimate of ($0.01) by $0.01 with a reported earnings per share (EPS) of ($0.02). Learn more on analysts' earnings estimate vs. MREO's actual earnings. How much revenue does Mereo BioPharma Group generate each year? Mereo BioPharma Group (NASDAQ:MREO) has a recorded annual revenue of $10 million. How much profit does Mereo BioPharma Group generate each year? Mereo BioPharma Group (NASDAQ:MREO) has a recorded net income of -$43.25 million. MREO has generated -$0.07 earnings per share over the last four quarters. What is Mereo BioPharma Group's EPS forecast for next year? Mereo BioPharma Group's earnings are expected to decrease from ($0.03) per share to ($0.04) per share in the next year. More Earnings Resources from MarketBeat Related Companies Nuvation Bio Earnings Results WAVE Life Sciences Earnings Results atai Life Sciences Earnings Results Oric Pharmaceuticals Earnings Results Sionna Therapeutics Earnings Results Pharming Group Earnings Results Maze Therapeutics Earnings Results Cronos Group Earnings Results Trevi Therapeutics Earnings Results ARS Pharmaceuticals Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 Earnings This page (NASDAQ:MREO) was last updated on 9/30/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuy this stock tomorrowFamed futurist Eric Fry just unveiled his “Sell This, Buy That” strategy — including 7 free trade ideas like a...InvestorPlace | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Mereo BioPharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
